coiaward2010

Treatment-free remission in chronic myeloid leukemia

nccnguide

Stopping Treatment in CML has now become a standard care with the publication of the NCCN and ESMO guidelines which include stopping treatment outside the context of clinical trials. The ELN recommendations are expected in few months and will relate to this hot topic as well.

At the same time, there are many questions patients have about the process.

In the following video Giora Sharf, the co-founder of CML Advocates Network and a CML patient on TFR for 3.5 years, interviews one of the world CML experts Prof. Giuseppe Saglio from University of Turin Italy, trying to answer some of the concerns CML patients have when thinking about stopping treatment. For example:

 

What is treatment-free remission concept?

What is the longer period of time that a patient has been on TFR?

Who are the patients eligible for TFR?

How many patients have to restart the treatment after TFR and when?

How can the psychological aspects on TFR be overcome?

What is the standard of monitoring a patient on TFR?

To watch to video click here:

 


 
   
 

Please donate!

Please donate!

LogIn